Status:

UNKNOWN

Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies

Lead Sponsor:

The First Affiliated Hospital of Soochow University

Conditions:

Hematological Malignancies

Chimeric Antigen Receptor T-cell Therapy

Eligibility:

All Genders

16-65 years

Brief Summary

The purpose of this prospective and observational study is to evaluate the correlation between gut microbiota and clinical response to CAR-T treatment for hematological malignancies

Detailed Description

Chimeric antigen receptor T-cell (CAR-T) therapy has shown impressive efficacy in hematological malignancies. However, response rates and associated immune-related adverse effects widely vary among pa...

Eligibility Criteria

Inclusion

  • Age 16-65 years.
  • Hematologic malignancies intended for CAR-T therapy.
  • Expected survival time ≥ 3 months (according to investigator's judgement).
  • Left ventricular ejection fractions ≥ 55% by echocardiography.
  • ALT / AST \<3 times of normal amounts.
  • Creatinine\<2.0mg/dl.
  • PT and APPT \<2 times of normal amounts.
  • Karnofsky performance status ≥ 60.
  • The ECOG score ≤2 points.

Exclusion

  • Pregnant (or lactating) women;
  • Uncontrolled active infection;
  • Active infection of hepatitis B virus or hepatitis C virus;
  • Human immunodeficiency virus (HIV) positive;
  • Patients with a history of myocardial infarction or severe arrhythmia within six months or those with class III or IV cardiac function according to the New York classification;
  • Any situations that the investigator believes may increase the risk of patients or interfere with the results of study.

Key Trial Info

Start Date :

September 3 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 2 2025

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06041815

Start Date

September 3 2023

End Date

March 2 2025

Last Update

September 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital of Soochow University

Suzhou, Jiangsu, China, 215006